Novo Nordisk Inc. et al v. Alvogen, Inc. > Summary
Court Case Number 1:22-cv-00299
Filing Date Mar 4, 2022
Termination Date Jan 10, 2024
Court Delaware District Court
Status Dismissed - Other
JudgesColm F. Connolly
Plaintiff
Defendant
Plaintiff Attorneys
8Novo Nordisk
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Novo Nordisk
Attorney Name: Brian P. Egan
Morris Nichols Arsht & Tunnell
Novo Nordisk
Attorney Name: Kara N. Czekai
Fenwick & West LLP
Novo Nordisk
Attorney Name: Laura Moran
Fenwick & West LLP
Novo Nordisk
Attorney Name: Erica Ruth Sutter
Fenwick & West LLP
Novo Nordisk
Attorney Name: Ryan Johnson
Fenwick & West LLP
Novo Nordisk
Attorney Name: Jeffrey J. Oelke
Fenwick & West LLP
Novo Nordisk
Attorney Name: Robert E. Counihan
Fenwick & West LLP
Defendant Attorneys
12Alvogen
Attorney Name: Emily S. Dibenedetto
Shaw Keller LLP
Alvogen
Attorney Name: Chantelle D. Ankerman
Axinn Veltrop & Harkrider
Alvogen
Attorney Name: Matthew J. Becker
Axinn Veltrop & Harkrider
Alvogen
Attorney Name: Karen E. Keller
Shaw Keller LLP
Alvogen
Attorney Name: Joshua S. Reisberg
Axinn Veltrop & Harkrider
Alvogen
Attorney Name: Chantelle D. Ankerman
Axinn Veltrop & Harkrider
Attorney Name: Chantelle D. Ankerman
Attorney Name: Chantelle D. Ankerman
Alvogen
Attorney Name: Chantelle D. Ankerman
Alvogen
Attorney Name: Joshua S. Reisberg
Alvogen
Attorney Name: Matthew J. Becker
Alvogen
Attorney Name: Joshua S. Reisberg
Counter Defendant
10Novo Nordisk
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Novo Nordisk
Attorney Name: Brian P. Egan
Morris Nichols Arsht & Tunnell
Novo Nordisk
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Novo Nordisk
Attorney Name: Brian P. Egan
Morris Nichols Arsht & Tunnell
Novo Nordisk
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Novo Nordisk
Attorney Name: Brian P. Egan
Morris Nichols Arsht & Tunnell
Novo Nordisk
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Novo Nordisk
Attorney Name: Brian P. Egan
Morris Nichols Arsht & Tunnell
Novo Nordisk
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Novo Nordisk
Attorney Name: Brian P. Egan
Morris Nichols Arsht & Tunnell
Counter Claimant
6Alvogen
Attorney Name: Emily S. Dibenedetto
Shaw Keller LLP
Alvogen
Attorney Name: Karen E. Keller
Shaw Keller LLP
Alvogen
Attorney Name: Karen E. Keller
Shaw Keller LLP
Alvogen
Attorney Name: Emily S. Dibenedetto
Shaw Keller LLP
Alvogen
Attorney Name: Karen E. Keller
Shaw Keller LLP
Alvogen
Attorney Name: Emily S. Dibenedetto
Shaw Keller LLP
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
11097063 | Syringe device with a dose limiting mechanism and an additional safety mechanism | Aug 24, 2021 |
10335462 | Use of long-acting GLP-1 peptides | Jul 2, 2019 |
10220155 | Syringe device with a dose limiting mechanism and an additional safety mechanism | Mar 5, 2019 |
09775953 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left | Oct 3, 2017 |
09687611 | Injection device with torsion spring and rotatable display | Jun 27, 2017 |
RE046363 | Dial-down mechanism for wind-up pen | Apr 11, 2017 |
09457154 | Injection device with an end of dose feedback mechanism | Oct 4, 2016 |
09132239 | Dial-down mechanism for wind-up pen | Sep 15, 2015 |
08920383 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left | Dec 30, 2014 |
08129343 | Acylated GLP-1 compounds | Mar 6, 2012 |